{"id":"https://openalex.org/W4392701034","doi":"https://doi.org/10.1158/1535-7163.c.6543928.v1","title":"Data from Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies","display_name":"Data from Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies","alternate_titles":[],"publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4392701034","doi":"https://doi.org/10.1158/1535-7163.c.6543928.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.c.6543928.v1","doi":"https://doi.org/10.1158/1535-7163.c.6543928.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6543928.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"parent_works":[],"lineage":["https://openalex.org/W4392701034"],"child_works_count":0,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.c.6543928.v1","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086670244","display_name":"Aaron Burmeister","orcid":"https://orcid.org/0000-0001-6714-9916","observed_orcids":["https://orcid.org/0000-0001-6714-9916"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aaron Burmeister","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6714-9916","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019015760","display_name":"Alexa Stephan","orcid":"https://orcid.org/0000-0002-0942-5764","observed_orcids":["https://orcid.org/0000-0002-0942-5764"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexa Stephan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0942-5764","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072519972","display_name":"Leandro A. Alves Avelar","orcid":"https://orcid.org/0000-0001-7394-3286","observed_orcids":["https://orcid.org/0000-0001-7394-3286"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leandro A. Alves Avelar","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7394-3286","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012115707","display_name":"Melanie M\u00fcller","orcid":"https://orcid.org/0000-0001-9430-1370","observed_orcids":["https://orcid.org/0000-0001-9430-1370"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melanie R. M\u00fcller","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9430-1370","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010787493","display_name":"Andrea Seiwert","orcid":"https://orcid.org/0000-0002-0050-0158","observed_orcids":["https://orcid.org/0000-0002-0050-0158"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrea Seiwert","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0050-0158","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048288399","display_name":"Stefan H\u00f6fmann","orcid":"https://orcid.org/0000-0003-0588-6974","observed_orcids":["https://orcid.org/0000-0003-0588-6974"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stefan H\u00f6fmann","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0588-6974","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071664903","display_name":"Fabian Fischer","orcid":"https://orcid.org/0000-0003-1140-2024","observed_orcids":["https://orcid.org/0000-0003-1140-2024"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fabian Fischer","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1140-2024","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070481215","display_name":"H\u00e9ctor Torres\u2010G\u00f3mez","orcid":"https://orcid.org/0000-0002-2220-8588","observed_orcids":["https://orcid.org/0000-0002-2220-8588"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hector Torres-Gomez","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2220-8588","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024945919","display_name":"Mich\u00e8le J. Hoffmann","orcid":"https://orcid.org/0000-0002-6044-1671","observed_orcids":["https://orcid.org/0000-0002-6044-1671"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mich\u00e8le J. Hoffmann","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6044-1671","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088518431","display_name":"G\u00fcnter Niegisch","orcid":"https://orcid.org/0000-0001-6929-8691","observed_orcids":["https://orcid.org/0000-0001-6929-8691"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guenter Niegisch","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6929-8691","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018790364","display_name":"Felix Bremmer","orcid":"https://orcid.org/0000-0003-0367-6527","observed_orcids":["https://orcid.org/0000-0003-0367-6527"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Felix Bremmer","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0367-6527","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033100401","display_name":"Patrick Petzsch","orcid":"https://orcid.org/0000-0002-8355-5524","observed_orcids":["https://orcid.org/0000-0002-8355-5524"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patrick Petzsch","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8355-5524","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066191006","display_name":"Karl K\u00f6hrer","orcid":"https://orcid.org/0000-0003-3644-2022","observed_orcids":["https://orcid.org/0000-0003-3644-2022"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karl K\u00f6hrer","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3644-2022","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068364488","display_name":"Peter Albers","orcid":"https://orcid.org/0000-0002-1747-9615","observed_orcids":["https://orcid.org/0000-0002-1747-9615"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Albers","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1747-9615","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002848963","display_name":"Thomas Kurz","orcid":"https://orcid.org/0000-0002-9474-4224","observed_orcids":["https://orcid.org/0000-0002-9474-4224"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Kurz","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9474-4224","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068715101","display_name":"Margaretha A. Skowron","orcid":"https://orcid.org/0000-0003-2152-384X","observed_orcids":["https://orcid.org/0000-0003-2152-384X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Margaretha A. Skowron","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2152-384X","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5051141861","display_name":"Daniel Nettersheim","orcid":"https://orcid.org/0000-0002-4483-845X","observed_orcids":["https://orcid.org/0000-0002-4483-845X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Nettersheim","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4483-845X","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.9564999938011169,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.9564999938011169,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.03189999982714653,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.007499999832361937,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.7860000133514404},{"id":"https://openalex.org/keywords/bet-inhibitors","display_name":"BET inhibitors","score":0.9900000095367432},{"id":"https://openalex.org/keywords/germ-cell-tumors","display_name":"germ cell tumors","score":0.9049999713897705},{"id":"https://openalex.org/keywords/urological-cancer","display_name":"genitourinary cancer","score":0.8880000114440918},{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.8970000147819519},{"id":"https://openalex.org/keywords/renal-carcinoma","display_name":"renal carcinoma","score":0.8360000252723694},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.8999999761581421},{"id":"https://openalex.org/keywords/cisplatin-resistance","display_name":"cisplatin resistance","score":0.9950000047683716},{"id":"https://openalex.org/keywords/chromatin-accessibility","display_name":"chromatin accessibility","score":0.9229999780654907},{"id":"https://openalex.org/keywords/epigenetic-therapy","display_name":"epigenetic therapy","score":0.6940000057220459},{"id":"https://openalex.org/keywords/neuroendocrine-differentiation","display_name":"neuroendocrine differentiation","score":0.8650000095367432},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7369999885559082},{"id":"https://openalex.org/keywords/cell-cycle","display_name":"cell cycle","score":0.6589999794960022},{"id":"https://openalex.org/keywords/xenograft-tumor-model","display_name":"xenograft tumor model","score":0.7509999871253967}],"concepts":[{"id":"https://openalex.org/C2776938808","wikidata":"https://www.wikidata.org/wiki/Q1737977","display_name":"Germ cell tumors","level":3,"score":0.6444838643074036},{"id":"https://openalex.org/C2780980858","wikidata":"https://www.wikidata.org/wiki/Q110022","display_name":"Dual (grammatical number)","level":2,"score":0.5970360040664673},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.48005354404449463},{"id":"https://openalex.org/C2779122487","wikidata":"https://www.wikidata.org/wiki/Q281579","display_name":"Germ cell","level":3,"score":0.43072250485420227},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.36087125539779663},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.218450129032135},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18521928787231445},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.16001641750335693},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06972593069076538},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C142362112","wikidata":"https://www.wikidata.org/wiki/Q735","display_name":"Art","level":0,"score":0.0},{"id":"https://openalex.org/C124952713","wikidata":"https://www.wikidata.org/wiki/Q8242","display_name":"Literature","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.c.6543928.v1","doi":"https://doi.org/10.1158/1535-7163.c.6543928.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6543928.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.c.6543928.v1","doi":"https://doi.org/10.1158/1535-7163.c.6543928.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.c.6543928.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9907000064849854}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4394097963","https://openalex.org/W1487934687","https://openalex.org/W2781495205","https://openalex.org/W4392688102","https://openalex.org/W7037197043","https://openalex.org/W2265659810","https://openalex.org/W2601491802","https://openalex.org/W4210422039","https://openalex.org/W4362542186","https://openalex.org/W6946312269"],"abstract_inverted_index":{"Abstract":[0],"Urological":[1],"malignancies":[2],"represent":[3,190],"major":[4],"challenges":[5],"for":[6,28,195,213,224],"clinicians,":[7],"with":[8,77],"annually":[9],"rising":[10],"incidences.":[11],"In":[12,31,182],"addition,":[13],"cisplatin":[14],"treatment":[15,193],"induced":[16,87],"long-term":[17],"toxicities":[18],"and":[19,43,45,58,73,81,89,140,145,187,205,221],"the":[20,26,36,78,91,175,209,218,225],"development":[21],"of":[22,38,65,119,126,161,178,208,217],"therapy":[23],"resistance":[24],"emphasize":[25],"need":[27],"novel":[29,39],"therapeutics.":[30],"this":[32],"study,":[33],"we":[34,199],"analyzed":[35],"effects":[37],"histone":[40],"deacetylase":[41],"(HDAC)":[42],"bromodomain":[44],"extraterminal":[46],"domain-containing":[47],"(BET)":[48],"inhibitors":[49,83,189],"to":[50,59,112,138],"combine":[51],"them":[52],"into":[53],"a":[54,95,107,116,155,191,214],"potent":[55],"HDAC-BET-fusion":[56],"molecule":[57],"understand":[60],"their":[61],"molecular":[62,108,204],"mode-of-action.":[63],"Treatment":[64],"(cisplatin-resistant)":[66],"germ":[67],"cell":[68,85,92],"tumors":[69],"(GCT),":[70],"urothelial,":[71],"renal,":[72],"prostate":[74],"carcinoma":[75],"cells":[76],"HDAC,":[79,185],"BET,":[80,186],"dual":[82,96,188],"decreased":[84,99],"viability,":[86],"apoptosis,":[88],"affected":[90],"cycle.":[93],"Furthermore,":[94,198],"inhibitor":[97,131,172,180],"considerably":[98],"tumor":[100],"burden":[101],"in":[102],"GCT":[103],"xenograft":[104],"models.":[105],"On":[106],"level,":[109,157],"correlating":[110],"RNA-":[111],"ATAC-sequencing":[113],"data":[114],"indicated":[115],"considerable":[117],"induction":[118],"gene":[120],"expression,":[121],"accompanied":[122],"by":[123],"site-specific":[124],"changes":[125],"chromatin":[127,152],"accessibility":[128,153,166],"after":[129,170],"HDAC":[130,171,179],"application.":[132],"Upregulated":[133],"genes":[134],"could":[135],"be":[136],"linked":[137],"intra-":[139],"extra-cellular":[141],"trafficking,":[142],"cellular":[143],"organization,":[144],"neuronal":[146],"processes,":[147],"including":[148],"neuroendocrine":[149],"differentiation.":[150],"Regarding":[151],"on":[154,202],"global":[156],"an":[158],"equal":[159],"distribution":[160],"active":[162],"or":[163],"repressed":[164],"DNA":[165],"has":[167],"been":[168],"detected":[169],"treatment,":[173],"questioning":[174],"current":[176],"understanding":[177,216],"function.":[181],"summary,":[183],"our":[184],"new":[192,203],"alternative":[194],"urological":[196],"malignancies.":[197],"shed":[200],"light":[201],"epigenetic":[206],"mechanisms":[207],"tested":[210],"epi-drugs,":[211],"allowing":[212],"better":[215],"underlying":[219],"modes-of-action":[220],"risk":[222],"assessment":[223],"patient.":[226]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4392701034","counts_by_year":[],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2024-03-13T00:00:00"}
